Shancheng Ren, MD,PhD

Rare Disease / Clinical Research

Shanghai Changzheng Hospital

PI on 2 trials

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Growth delay due to insulin-like growth factor I resistance
Acquired cystic disease-associated renal cell carcinoma

Clinical trials (2)

NCT06866548
NCT06586658

Verify independently

ClinicalTrials.gov PI search for Shancheng Ren, MD,PhD

Other specialists for Growth delay due to insulin-like growth factor I resistance

Peers ranked by clinical-trial PI role, publications, and verification quality.

James Yao
M.D. Anderson Cancer Center
Armando Santoro, MD
Istituto Clinico Humanitas
Robert O'Donnell
University of California, Davis
Andrew B Hassan, BMBCh FRCP
University of Oxford
Alberto Chiappori, MD
Moffitt Cancer Center
FL
Kevin Judy, MD, MD
Thomas Jefferson University
PA
Eric Burak, PhD
Centre for Probe Development and Commercialization
Michael Bergqvist, M.D., Ph.D
Uppsala University Hospital

See all specialists for Growth delay due to insulin-like growth factor I resistance →

← Back to specialists directory